Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acipimox during exercise for glycemic control in type 2 diabetes
NL-OMON22784Recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of acipimox in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: 24-hour glycemic control. Started Aug 2014; status: recruiting.
02
Drugs
acipimox
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON22784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22784.